BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kovacs E. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Biomedicine & Pharmacotherapy 2003;57:489-94. [DOI: 10.1016/j.biopha.2003.08.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Wan S, Zhou Z, Duan B, Morel L. Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 2008;58:1741-50. [PMID: 18512810 DOI: 10.1002/art.23515] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
2 Xu S, Neamati N. gp130: a promising drug target for cancer therapy. Expert Opinion on Therapeutic Targets 2013;17:1303-28. [DOI: 10.1517/14728222.2013.830105] [Cited by in Crossref: 39] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
3 Pal R, Janz M, Galson DL, Gries M, Li S, Jöhrens K, Anagnostopoulos I, Dörken B, Mapara MY, Borghesi L, Kardava L, Roodman GD, Milcarek C, Lentzsch S. C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. Blood 2009;114:3890-8. [PMID: 19717648 DOI: 10.1182/blood-2009-01-201111] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
4 Sahara N, Takeshita A, Ono T, Sugimoto Y, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Shibata K, Otsuki T, Hayashi H, Ohnishi K. Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56− and CD56+ multiple myeloma cells. Experimental Hematology 2006;34:736-44. [DOI: 10.1016/j.exphem.2006.02.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
5 Kovacs E. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells? Leukemia Research 2010;34:912-6. [DOI: 10.1016/j.leukres.2009.08.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
6 Gao L, Zhang C, Zhang X, Gao L, Hao L, Chen XH. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells. Hematology 2014;19:148-57. [PMID: 23896383 DOI: 10.1179/1607845413Y.0000000107] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Li L, Wang L. Multiple Myeloma: What Do We Do About Immunodeficiency? J Cancer 2019;10:1675-84. [PMID: 31205523 DOI: 10.7150/jca.29993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yosifov DY, Reufsteck C, Konstantinov SM, Berger MR. Interleukin-6, osteopontin and Raf/MEK/ERK signaling modulate the sensitivity of human myeloma cells to alkylphosphocholines. Leuk Res 2012;36:764-72. [PMID: 22421411 DOI: 10.1016/j.leukres.2012.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]